Mitchell Stephen Ray
SEC CIK 1802653 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | Dir | 112.8K | — | $442.8K | 12 | 2021-09-09 | 2026-06-04 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-08 16:15 | 2026-06-04 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +41.6K | 112.8K | +58% | $0 | |
| 2026-05-20 16:49 | 2026-05-18 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | G - Gift | $0.00 | -25.8K | 71.2K | -27% | $0 | |
| 2025-06-16 | 2025-06-13 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | S - Sale | $4.59 | -7,000 | 97.1K | -7% | -$32.1K | |
| 2025-06-09 | 2025-06-05 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +59.2K | 104.1K | +132% | $0 | |
| 2024-11-18 | 2024-11-14 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | S - Sale | $5.17 | -5,000 | 44.9K | -10% | -$25.9K | |
| D | 2024-05-21 | 2024-05-17 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +20.5K | 49.9K | +70% | $0 |
| 2023-08-11 | 2023-08-10 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | S - Sale | $6.05 | -6,500 | 29.3K | -18% | -$39.3K | |
| D | 2023-06-12 | 2023-06-08 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +17.3K | 35.8K | +93% | $0 |
| D | 2022-06-21 | 2022-06-16 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +12.0K | 18.5K | +184% | $0 |
| 2022-06-14 | 2022-06-13 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | S - Sale | $9.48 | -2,700 | 6,515 | -29% | -$25.6K | |
| D | 2021-09-13 | 2021-09-09 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | S - Sale+OE | $16.74 | -19.1K | 9,215 | -67% | -$319.9K |
| DM | 2021-09-13 | 2021-09-09 | VNDA | Vanda Pharmaceuticals Inc. | Mitchell Stephen Ray | Dir | M - OptEx | $12.03 | +19.1K | 28.3K | +207% | +$229.9K |
Purchase Sale Sale after option exercise All abbreviations